Guideline
Open Access
Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk
Ainsley Moore, Gregory Traversy, Donna L. Reynolds, John J. Riva, Guylène Thériault, Brenda J. Wilson, Melissa Subnath and Brett D. Thombs; for the Canadian Task Force on Preventive Health Care
CMAJ April 19, 2021 193 (16) E549-E559; DOI: https://doi.org/10.1503/cmaj.201967
Ainsley Moore
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
MD MScGregory Traversy
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
MScDonna L. Reynolds
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
MD MScJohn J. Riva
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
DC PhDGuylène Thériault
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
MDBrenda J. Wilson
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
MB ChB MSc MRCP (UK)Melissa Subnath
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
MScBrett D. Thombs
Department of Family Medicine (Moore), McMaster University, Hamilton, Ont.; Public Health Agency of Canada (Subnath, Traversy), Ottawa, Ont.; Department of Family and Community Medicine (Reynolds), University of Toronto, Toronto, Ont.; Department of Family Medicine (Riva), McMaster University, Hamilton, Ont.; Faculty of Medicine (Thériault) McGill University, Montréal, Que.; Division of Community Health and Humanities (Wilson), Memorial University, NFLD; Lady Davis Institute and Department of Psychiatry (Thombs), Jewish General Hospital and McGill University, Montréal, Que.
PhDData supplements
Online appendices
- Appendix 1: Benefits of screening for chlamydia among general risk individuals
- Appendix 2: Analytical Framework
- Appendix 3: Screening for Chlamydia and Gonorrhea: Evidence to Decision Framework
- Appendix 4: Competing interests for clinical and content experts for the “Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk” guideline
Podcast
Related Articles
- Grennan, T., & Tan, D. H. (2021). Benefits of opportunistic screening for sexually transmitted infections in primary care. CMAJ, 193(16), E566-E567. Accessed August 17, 2024. https://doi.org/10.1503/cmaj.210604.
- Moore, A., Traversy, G., Reynolds, D. L., Riva, J. J., Thériault, G., Wilson, B. J., Subnath, M., Thombs, B. D., & , . (2021). Recommandation relative au dépistage de la chlamydia et de la gonorrhée en soins primaires chez les personnes non connues comme appartenant à un groupe à risque. CMAJ, 193(16), E573-E584. Accessed August 17, 2024. https://doi.org/10.1503/cmaj.201967-f.
- Whellams, D. (2021). Screening for chlamydia and gonorrhea in primary care in populations with low prevalence. CMAJ, 193(33), E1307. Accessed August 17, 2024. https://doi.org/10.1503/cmaj.79560.
In this issue
Article extras
Article tools
Respond to this article
Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk
Ainsley Moore, Gregory Traversy, Donna L. Reynolds, John J. Riva, Guylène Thériault, Brenda J. Wilson, Melissa Subnath, Brett D. Thombs
CMAJ Apr 2021, 193 (16) E549-E559; DOI: 10.1503/cmaj.201967
Recommendation on screening for chlamydia and gonorrhea in primary care for individuals not known to be at high risk
Ainsley Moore, Gregory Traversy, Donna L. Reynolds, John J. Riva, Guylène Thériault, Brenda J. Wilson, Melissa Subnath, Brett D. Thombs
CMAJ Apr 2021, 193 (16) E549-E559; DOI: 10.1503/cmaj.201967
Jump to section
Related Articles
Cited By...
- Approche pratique au diagnostic et a la prise en charge de la chlamydia et de la gonorrhee
- A practical approach to the diagnosis and management of chlamydia and gonorrhea
- Estimating the test-adjusted incidence of Chlamydia trachomatis infections identified through Public Health Ontario Laboratories in Peel region, Ontario, 2010-2018: a population-based study
- Rapid recommendations: Updates from 2021 guidelines: part 2
- Screening for chlamydia and gonorrhea in primary care in populations with low prevalence
- Avantages du depistage opportuniste des infections transmissibles sexuellement en medecine de soins primaires
- Benefits of opportunistic screening for sexually transmitted infections in primary care